Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Oct 12;16(10):e0258336. doi: 10.1371/journal.pone.0258336

Practical considerations for Ultraviolet-C radiation mediated decontamination of N95 respirator against SARS-CoV-2 virus

Guillaume R Golovkine 1,#, Allison W Roberts 1,#, Chase Cooper 2, Sebastian Riano 2, Angela M DiCiccio 2, Daniel L Worthington 2, Jeffrey P Clarkson 2, Michael Krames 3, Jianping Zhang 4, Ying Gao 4, Ling Zhou 4, Scott B Biering 5, Sarah A Stanley 1,5,*
Editor: Ginny Moore6
PMCID: PMC8509861  PMID: 34637475

Abstract

Decontaminating N95 respirators for reuse could mitigate shortages during the COVID-19 pandemic. Although the United States Center for Disease Control has identified Ultraviolet-C irradiation as one of the most promising methods for N95 decontamination, very few studies have evaluated the efficacy of Ultraviolet-C for SARS-CoV-2 inactivation. In addition, most decontamination studies are performed using mask coupons that do not recapitulate the complexity of whole masks. We sought to directly evaluate the efficacy of Ultraviolet-C mediated inactivation of SARS-CoV-2 on N95 respirators. To that end we created a portable UV-C light-emitting diode disinfection chamber and tested decontamination of SARS-CoV-2 at different sites on two models of N95 respirator. We found that decontamination efficacy depends on mask model, material and location of the contamination on the mask. Our results emphasize the need for caution when interpreting efficacy data of UV-C decontamination methods.

Introduction

The limited availability of N95 respirators during the SARS-CoV-2 pandemic has forced many healthcare workers to reuse respirators designed for one-time use. In these circumstances, the development of safe and efficient methods of decontamination of N95 respirators could be a partial solution to shortages [1]. The U. S. Center for Disease Control (CDC) has identified ultraviolet germicidal irradiation (UVGI), vaporous hydrogen peroxide and moist heat as the 3 most promising methods for N95 decontamination during a crisis capacity situation [1, 2].

The efficacy of UVGI for decontamination of bacteria and viruses on N95 respirators has been extensively investigated [3]. Ultraviolet-C (UV-C) exposure has been identified as an efficient method for inactivation of several viruses [4, 5], including respiratory viruses such as influenza [68], SARS-CoV or MERS-CoV [9]. However, important variability was reported depending on the N95 mask model studied [6, 9]. Very few studies directly evaluate UV-C mediated inactivation of SARS-CoV-2 on N95 respirators [1012]. Fischer et al. demonstrated that UV-C could effectively decontaminate SARS-CoV-2 on N95 respirator [11]. However, this study was performed using small, flat mask coupons that do not recapitulate angular incidence and shadowing effects caused by the 3D structure of the masks and could therefore underestimate the levels of UV-C irradiation required for effective decontamination of an intact respirator [13]. Recently, Ozog et al. tested UV-C decontamination on whole N95 respirators and reported important variations of decontamination efficacy between different N95 models and material [12], which correlates with previous results with H1N1 influenza [6, 9]. However, in this study the virus recovery from unirradiated masks for several of the models was not sufficiently above the limit of detection to determine whether effective decontamination was achieved as defined the U.S. Food & Drug Administration (FDA) as a minimum of 3 log10 reduction in viable virus [14].

The COVID-19 pandemic and the associated shortage in N95 supplies have triggered the rapid emergence of new implementation strategies for decontamination methods and the creation of new UVGI devices [2]. During the first months of the COVID-19 pandemic, the University of Nebraska Medical Center, followed by other groups, published protocols for the implementation of UV-C based decontamination of N95 [15]. In April 2020, during the peak on the COVID-19 pandemic, the Henry Ford Health System and other hospital settings used UV-C to decontaminate N95 respirators for health care workers [12, 16]. However, as of April 2021, only one UVGI device had received an Emergency Use Authorization (EUA) from the FDA [14].

We aimed to determine the efficacy of UVGI for decontamination of SARS-CoV-2 on intact N95 respirators. To evaluate whether the 3D structure of the masks impacted inactivation of SARS-CoV-2, we tested decontamination at several sites on the respirators. We found that the efficacy of decontamination is significantly influenced by the structure of the mask and corresponding differences in irradiation. We also sought to directly evaluate whether the efficacy of decontamination varies between different models of N95 made with different materials.

Materials and methods

Virus preparation

The SARS-CoV-2 strain used was USA-WA1/2020. Viral stocks were obtained from the Biodefense and Emerging Infections Research Resources Repository. Stocks were amplified in Vero-E6 cells (passage 1) and again in Calu-3 cells (passage 2). Virus passage 2 was used for experiments and was determined to have a concentration of 8 x 107 TCID50/ml. Additional details in S1 File.

Mask inoculation

Five locations (center, top, bottom, right cheek, and strap) on the exterior of the masks were inoculated with a total of 50 μl of virus stock. The locations were selected after consideration of the 3D structure of the mask and corresponding differences in irradiation dose received to cover a wide range of anticipated doses. Aluminum coupons adhered to the center of the masks were used as a smooth and non-porous control surface. Aluminum coupons were bent to follow the shape of the mask and placed in a location calculated to receive irradiation doses equivalent to the “center” mask location.

To allow surface tension to contain the virus in droplets on non-horizontal surfaces, virus was inoculated in 3 aliquots of 16.67 μl. The 3 aliquots were inoculated simultaneously and spaced such that they could not merge but all fit within the size of a 12 mm biopsy punch. Masks were left to dry for 3.5 hours in a biosafety cabinet (Nuaire LabGard model NU-540-600). Straps of 3M 1860 masks were inoculated with 50 μl of SARS-CoV-2 only 10 minutes before irradiation because optimization experiments showed that virus viability on this material decreased with excessive drying (unpublished data). Desiccation on mask facepieces or aluminum coupons for 3.5 hours did not significantly affect virus concentration (S3 Fig).

UV-C exposure

We created a UVGI device for N95 decontamination designed to generate high levels of reflection and enable ease of use via straightforward fixturing and application. The decontamination chamber consists of a metal reflecting box containing high power, commercially available UV LEDs with driver circuitry on metal core printed PCBs mounted on the vertical walls of the chamber (S1 Fig). Individual masks were placed inside the chamber by attaching their upper and lower head bands to attachment points that ensured consistent placement inside the chamber. Eight LEDs were arrayed on each vertical sidewall in a fashion to optimize exposure dose uniformity across the surface of an N95 respirator and were calibrated to deliver a minimum irradiance of 1 mW/cm2 across all locations of the mask (S2 Fig and S1 Table). The temperature of the metal core circuit board, to which the UV LEDs were mounted to, remained below 41°C for all disinfection runs.

Immediately before irradiation, 2 pieces of UV tape were added to the upper right and lower left corners of the mask. Masks were placed one at a time into the device by attaching the straps on mounting points located at the top and bottom. Masks were irradiated for 300 sec or 600 sec. A picture of the mask was taken after irradiation to document UV tape change of color. To ensure that no loss of virus viability occurred due to desiccation time, virus from non-exposed control masks were harvested after all masks were exposed and biopsies were taken. Control masks were not placed into the device.

Virus titration

Inoculated regions of the mask were cut out using 12 mm biopsy punches. Samples were incubated in 1.4 ml (mask punches and aluminum coupons) or 2 ml (strap pieces) of DMEM (Sigma-Aldrich) supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin for a minimum of 30 minutes and subjected to gentle manual agitation at the beginning and end of the incubation. Virus was quantified by TCID50 assay by incubating Vero E6 cells in 96 well plates with 10-fold serial dilutions in 8-fold of incubation media. Five days after inoculation, cytopathic effect, defined as any virus induced cell death or change in cell morphology, was scored visually under brightfield illumination using a 4X / 0.13 NA objective. TCID50 was calculated using the Reed-Muench method. The limit of detection of the assay was 3.16 TCID50/ml, which was determined by calculating the TCID50 at which no CPE is observed in any replicate wells. The maximum log reduction that could be achieved for each mask location is shown in S2 Table.

Results and discussion

We tested decontamination of SARS-CoV-2 on two masks models, 3M 1860 and 3M 8210. Although both masks are approved for healthcare worker use during the COVID-19 pandemic, their outer layers have different shapes and are comprised of different materials. We wondered whether these differences would impact the efficacy of UV-C based decontamination. We analyzed decontamination of 5 different inoculated mask locations (center, top, bottom, right cheek and strap, Fig 1 panel A) as well as a control aluminum coupon adhered to center of the mask. Masks were exposed to UV-C for 0, 300 or 600 seconds. The minimal doses received at each location were greater than 300 and 600 mJ/cm2 for the 300 and 600 second exposures, respectively. Importantly, the UV-C doses used in our study were considerably lower than the cumulative doses reported to degrade N95 material [17].

Fig 1. UV-C decontamination of multiple locations on two models of N95 respirators.

Fig 1

(A) Schematic of mask inoculation sites. 3M 1860 and 3M 8210 masks were inoculated in five different locations plus an aluminum coupon adhered to the center of each mask. Each site was inoculated with 50 μl of 8e7 TCID50/ml virus, applied as three aliquots of 16.7 μl. Inoculated masks were allowed to dry for 3.5 hours at room temperature in a biosafety cabinet before masks were exposed to UV-C irradiation. UV tape was adhered to masks to confirm irradiation. (B and C) Viable SARS-COV-2 recovered from inoculation sites. Viable virus at each inoculation site was quantified by end-point titration on Vero E6 cells and expressed as 50% tissue-culture infectious dose 50 (TCID50) per site. Plots show the mean of two replicates from one experiment and are representative of two independent experiments. Dashed lines indicate the limit of detection (LOD), samples with no positive wells are plotted at LOD. (B) Data displayed by mask model; mean of data is displayed as a bar graph with individual sites shown as dots. (C) Data displayed by location of inoculation. * p < 0.05, ** p < 0.01, *** p < 0.001.

The CDC has issued specific recommendations on the reuse of N95 respirators as a crisis management strategy. Accordingly, the FDA requires “Tier 3” devices (bioburden reduction) to yield at least 3 log10 inactivation of various pathogens on N95 respirators [14]. Both UV-C doses achieved close to a 5 log10 reduction in virus on the aluminum control coupons (Fig 1, panel B and Table 1), validating the efficacy of our UV-C device to eliminate SARS-CoV-2 on non-porous material. However, the 300 second exposure was insufficient for decontamination when averaging locations across the masks (Fig 1, panel B and Table 1). The 600 second exposure effectively decontaminated the 3M 1860 masks but failed to decontaminate 3M 8210 masks (Fig 1, panel B and Table 1). Notably, there was little difference between the 300 and 600 second doses on the 8210 masks regardless of location, suggesting that increased exposure time does not achieve higher levels of decontamination of this mask surface.

Table 1. Average log10 reduction in viable SARS-CoV-2 recovered.

300 sec 600 sec
3M 1860 3M 8210 3M 1860 3M 8210
Total mask 2.67 2.05 3.74 1.68
Aluminum 4.95 [4.95–4.95] 4.92 [4.88–4.95] 4.95 [4.95–4.95] 4.86 [4.79–4.95]
Right 4.25 [3.99–4.99] 1.81 [1.78–1.85] 5.06 [5.06–5.06] 1.73 [1.68–1.78]
Center 2.44 [2.18–3.18] 1.90 [1.86–1.94] 4.26 [4.01–4.88] 1.94 [1.86–2.04]
Top 3.15 [2.86–4.29] 1.56 [1.41–1.81] 4.47 [4.36–4.61] 1.41 [1.41–1.41]
Bottom 2.41 [2.32–2.52] 1.72 [1.63–1.83] 3.28 [3.02–4.02] 2.21 [2.13–2.30]
Strap 1.10 [1.07–1.14] 3.24 [2.95–4.80] 1.63 [1.54–1.74] 1.10 [0.88–1.58]

Data is presented as the mean with lowest and highest values within brackets.

While the reduction averaged across the entire mask was greater than 3 log10 for the 3M 1860 mask at 600 seconds, there were important variations between different locations on the mask (Fig 1, panel C and Table 1). Irradiation doses were calculated using a representative 1860 model N95 mask with integrated irradiance sensors (S2 Fig). We determined that the smaller reduction in viral titer at the bottom location correlates with a lower irradiation dose received at this location. Conversely, the Right location received the highest irradiation dose and demonstrated effective decontamination of the 3M 1860 masks at the 300 sec and 600 sec exposures. However, neither dose at the Right location was sufficient for decontamination of the 3M 8210 masks (Fig 1, panel C), despite receiving the largest dose. Furthermore, the straps were difficult to decontaminate, with large variability (Fig 1, panel C), a result observed for other viruses [8]. We hypothesize that this is due to the strap material and potential shadowing effects caused by twists in the strap during exposure to UV-C.

These results suggest that some N95 respirator models are not compatible with UV-C based decontamination. Importantly, dose validation experiments were performed with both mask models and showed similar irradiances at each location. Therefore, differences in decontamination efficacy do not result from variations in the 3D shape of the masks but are likely due to differences in mask material. The 1860 model is designed to be fluid resistant and has a smooth polypropylene outer layer while the 8210 model is not considered fluid resistant and has a polyester outer layer. Our results suggest that the 1860 facepiece is more appropriate for UV-C decontamination than the 1860 strap (braided polyisoprene), the 8210 facepiece, or the 8210 straps (thermoplastic elastomers). Both the 1860 and 8210 facepieces are hydrophobic and virus inoculum was not absorbed into the material. Instead, virus droplets dried on the mask surface. Although, no loss of viability was observed during the 3.5 hours of drying time (S3 Fig), it is possible that desiccation could increase susceptibility of the virus to UV-C. Interestingly, we noted that the outer layer of the 8210 mask presents a rougher surface than the 1860 mask, which perhaps shields the virus from sufficient UV-C exposure and prevents efficient UV-C decontamination of this mask model.

Although our device was designed to expose the entirety of the masks to UV-C, our study focused on the decontamination of the outer layer of the mask only, which limits the conclusions to single-user applications. Although a system shown to effectively decontaminate both the interior and exterior of masks could streamline decontamination and allow for multiple-users, the use of respirators by single-users poses less risk of unintended transmission of SARS-CoV-2 or other pathogens [14] and could represent a viable crisis management strategy to help alleviate N95 shortages. It is important to note that UV-C decontamination methods should also ensure that N95 masks retain their fit and filtration capacities after UV-C exposure [18], which was not tested in this study.

While UV-C is an attractive method for decontamination of PPE when applied at appropriate doses that do not compromise material integrity and device functionality, our findings suggest that efficacy for individual mask models should be evaluated for a given UV-C device. Our results as well as the recent study by Ozog et al. [12] indicate that while the facepieces of some mask models can be successfully decontaminated using UV-C, others seem incompatible with this method of SARS-CoV-2 decontamination. Important factors to consider are the 3D structure of the mask and corresponding differences in irradiation dose received in some mask locations which can significantly influence the efficacy of decontamination. The straps may be particularly difficult to decontaminate and may require the use of a secondary method of decontamination in addition to UVGI [19]. However, UV-C LED technology is improving rapidly, and future devices will offer higher irradiation levels, improving penetration of UVGI and/or shortening exposure times. The identification of existing N95 models that are most suited for UV-C based decontamination or the creation of new mask models for this purpose would be important milestones that could help mitigate future N95 shortages.

Supporting information

S1 File. Extended material and methods.

(DOCX)

S2 File. Minimal data set.

(XLSX)

S1 Fig. Photo of a N95 respirator in the UVGI device.

Front panel was removed for visibility.

(TIF)

S2 Fig. Custom N95 respirator with calibrated sensors used for the measurement and according irradiance measurement at each site.

(TIFF)

S3 Fig. Comparison of virus recovery from unirradiated mask sites after virus desiccation to control virus added directly into recovery media.

(TIFF)

S1 Table. Calculated doses delivered at each location for each exposure.

Doses are calculated based on irradiance measurements made with the custom N95 respirator with calibrated sensors. Units are in mJ/cm2.

(DOCX)

S2 Table. Maximum log reduction achievable for each mask location.

(DOCX)

Acknowledgments

We thank Verily employees Greg Arcenio, Beth Bosworth, Warren Cai, Mike Chen, Junjia Ding, Tim English, Chopin Hua, David Heinz, Kyle Nichols, Supriyo Sinha for their valuable contributions and feedback.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was funded by Fast Grants (part of Emergent Ventures at George Mason University) to SAS. AWR is an Open Philanthropy Fellow of the Life Sciences Research Foundation. Authors CC, SR, AMD, DLW and JPC are employees of Verily Life Sciences. Authors JZ, YG, LZ are employees of Bolb, Inc. Author MK is President at Arkesso, LLC. The funders provided support in the form of salaries for authors CC, SR, AMD, DLW, JPC, JZ, YG, LZ, MK and support in the form of work hours and equipment for the authors to execute and collaborate in the study design, data collection and analysis. The funders permitted authors to proceed with the decision to publish, or preparation of the manuscript.

References

  • 1.Centers for Disease Control and Prevention. Implementing Filtering Facepiece Respirator (FFR) Reuse, Including Reuse after Decontamination, When There Are Known Shortages of N95 Respirators. [Internet]. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/decontamination-reuse-respirators.html
  • 2.Torres AE, Lyons AB, Narla S, Kohli I, Parks-Miller A, Ozog D, et al. Ultraviolet-C and other methods of decontamination of filtering facepiece N-95 respirators during the COVID-19 pandemic. Photochem Photobio S. 2020;19: 746–751. doi: 10.1039/d0pp00131g [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Grist SM, Geldert A, Gopal A, Su A, Balch HB, Herr AE. Current Understanding of Ultraviolet-C Decontamination of N95 Filtering Facepiece Respirators. Appl Biosaf. 2021. doi: 10.1089/apb.20.0051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Vo E, Rengasamy S, Shaffer R. Development of a Test System To Evaluate Procedures for Decontamination of Respirators Containing Viral Droplets▿. Appl Environ Microb. 2009;75: 7303–7309. doi: 10.1128/aem.00799-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Fisher EM, Shaffer RE. A method to determine the available UV‐C dose for the decontamination of filtering facepiece respirators. J Appl Microbiol. 2011;110: 287–295. doi: 10.1111/j.1365-2672.2010.04881.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mills D, Harnish DA, Lawrence C, Sandoval-Powers M, Heimbuch BK. Ultraviolet germicidal irradiation of influenza-contaminated N95 filtering facepiece respirators. Am J Infect Control. 2018;46(7):e49–55. doi: 10.1016/j.ajic.2018.02.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lore MB, Heimbuch BK, Brown TL, Wander JD, Hinrichs SH. Effectiveness of Three Decontamination Treatments against Influenza Virus Applied to Filtering Facepiece Respirators. Ann Occup Hyg. 2012;56(1):92–101. doi: 10.1093/annhyg/mer054 [DOI] [PubMed] [Google Scholar]
  • 8.Heimbuch BK, Wallace WH, Kinney K, Lumley AE, Wu C-Y, Woo M-H, et al. A pandemic influenza preparedness study: Use of energetic methods to decontaminate filtering facepiece respirators contaminated with H1N1 aerosols and droplets. Am J Infect Control. 2011;39(1):e1–9. doi: 10.1016/j.ajic.2010.07.004 [DOI] [PubMed] [Google Scholar]
  • 9.Heimbuch BK and Harnish D. Research to Mitigate a Shortage of Respiratory Protection Devices During Public Health Emergencies. [Internet]. 2019. Available from: https://www.ara.com/news/ara-research-mitigate-shortage-respiratory-protection-devices-during-public-health-emergencies
  • 10.Kumar A, Kasloff SB, Leung A, Cutts T, Strong JE, Hills K, et al. Decontamination of N95 masks for re-use employing 7 widely available sterilization methods. Plos One. 2020;15(12):e0243965. doi: 10.1371/journal.pone.0243965 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fischer RJ, Morris DH, Doremalen N van, Sarchette S, Matson MJ, Bushmaker T, et al. Early Release—Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus—Volume 26, Number 9—September 2020—Emerging Infectious Diseases journal—CDC. Emerg Infect Dis. 2020;26(9):2253–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ozog DM, Sexton JZ, Narla S, Pretto-Kernahan CD, Mirabelli C, Lim HW, et al. The Effect of Ultraviolet C Radiation Against Different N95 Respirators Inoculated with SARS-CoV-2. Int J Infect Dis. 2020; [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Narla S, Lyons AB, Kohli I, Torres AE, Parks‐Miller A, Ozog DM, et al. The importance of the minimum dosage necessary for UVC decontamination of N95 respirators during the COVID‐19 pandemic. Photodermatol Photoimmunol Photomed. 2020;36(4):324–5. doi: 10.1111/phpp.12562 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Recommendations for Sponsors Requesting EUAs for Decontamination and Bioburden Reduction Systems for Surgical Masks and Respirators During the Coronavirus Disease 2019 (COVID19) Public Health Emergency. https://www.fda.gov/media/138362/download (2020).
  • 15.Lowe JJ, Paladino KD, Farke JD, Boulter K, Cawcutt K, Emodi M, et al. N95 Filtering Facepiece Respirator Ultraviolet Germicidal Irradiation (UVGI) Process for Decontamination and Reuse. https://www.nebraskamed.com/sites/default/files/documents/covid-19/n-95-decon-process.pdf (accessed 2020). [Google Scholar]
  • 16.Golladay GJ, Leslie KA, Zuelzer WA, Cassano AD, Plauny JJ, Daniels FE, et al. Rationale and process for N95 respirator sanitation and re-use in the COVID-19 pandemic. Infect Control Hosp Epidemiology. 2021; 1–20. doi: 10.1017/ice.2021.37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lindsley WG, SBM Jr., Thewlis RE, Sarkisian K, Nwoko JO, Mead KR, et al. Effects of Ultraviolet Germicidal Irradiation (UVGI) on N95 Respirator Filtration Performance and Structural Integrity. J Occup Environ Hyg. 2015;12: 509–517. doi: 10.1080/15459624.2015.1018518 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ozog D, Parks-Miller A, Kohli I, Lyons AB, Narla S, Torres AE, et al. The Importance of Fit-Testing in Decontamination of N95 Respirators: A Cautionary Note. J Am Acad Dermatol. 2020;83: 672–674. doi: 10.1016/j.jaad.2020.05.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Xiaobao L, Buckley D, Dayton R, Grinstead D, Teska P, Becker L. Sequential UV-C and Thermal Decontamination for Reuse of N95 Face Masks during the COVID19 Pandemic. InfectionControl.tips. 2020;5:1–9. [Google Scholar]

Decision Letter 0

Ginny Moore

28 Apr 2021

PONE-D-21-00512

Practical considerations for Ultraviolet-C radiation mediated decontamination of N95 respirator against SARS-CoV-2 virus

PLOS ONE

Dear Dr. Stanley,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I am returning your manuscript with comments from two reviewers, who you will see, came to similar conclusions. Both found the paper very interesting but had a number of queries about the methods used. I agree that the methods section is currently very brief and important information is either missing or included as supplementary material rather than main text. For example, the treatment of control (non-exposed) masks/surfaces should be clarified - was virus recovered after the 3.5 h drying time (0 sec exposure) or were masks placed in the chamber and exposed to 0 mJ/cm2 for 300 and 600 seconds? Similarly, straps were not subjected to the 3.5 h drying time and, whilst it is stated (supplementary data) that no losses in viability occurred over the 3.5h drying time, could desiccation stress increase virus susceptibility to subsequent UV-c exposure? Whilst some of the additional information asked for by the reviewers can be considered supplementary, please ensure sufficient detail is provided within the main text. If possible, and as suggested by both reviewers, please also include a picture of the chamber and configuration of the masks within.

I would also draw specific attention to comments made by Reviewer 2 and their concerns relating to data interpretation. Please ensure your conclusions are supported by the data and that limitations of the study have been acknowledged.

Finally, and as highlighted by Reviewer 1, it could be perceived that some of the listed authors have competing interests. Please address and/or declare as appropriate.

Please submit your revised manuscript by May 23 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Ginny Moore

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Financial Disclosure section:

[This work was funded by Fast Grants (part of Emergent Ventures at George Mason University) to SAS. AWR is supported by a LSRF fellowship.].   

We note that one or more of the authors are employed by a commercial company: Verily Life Sciences, Arkesso LLC and Bolb Inc.

  1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Review of PONE-D-21-00512

Interesting short report showing differences in mask decontamination. Could do with more results because it was only completed twice for each mask and the results lack some potential significance in interpretation due to it. It would also be interesting to have completed the study on masks that had already been worn because this is how they would be presented when decontaminated in reality. There is no evaluation of the effects angular incidence causes on the decontamination results as mentioned in the introduction.

Conflicts of interest, there are authors from the companies that have produced the LEDs for the UV chamber you have used. I would say that this needs to be declared since you say that UVc is a technology that can be used to disinfect masks and will be improving in the future which could benefit the companies producing the LEDs.

Why did you choose the sites for the contamination of the masks?

Why did you only test two models of the mask? Was it because these were the only ones being used in the University or were they chosen because their properties were thought to give different results from the exposure?

The last sentence in the introduction is not needed.

How did you stop the droplet inoculum from spreading on the non-horizontal surfaces if they were all inoculated at the same time? How does this vary from just adding 50ul in one go? Were the 3 inoculums added to exactly the same spot? Did you add each inoculum and leave it to dry prior to adding the next? If not added together how does this represent contamination when masks are used in practice?

More information on the UVc exposure chamber is needed and positioning of the masks inside it, or was each mask exposed separately? Maybe a picture of the chamber would help in the description, the brief section in the results/discussion section should be moved into the materials and methods. Was there a temperature increase in the exposure device during operation?

More information on the methods is needed or should be included in the supplementary file. How was the CPE visualised, was a stain used?

Please explain what were the aluminium coupons used for (virus titration section)? Why were aluminium coupons chosen over stainless steel for coupons?

Were the coupons excised from the mask agitated in the recovery medium?

What was the loss of viability over the course of the experiment from exposure to the environmental conditions inside the UVc chamber without the LEDs being switched on? Could an increase in heat have contributed to the reduction in viability of the virus?

Please include a reference for the statement identifying that a 3-log reduction is the industry standard for an effective decontamination.

The results from the aluminium show a close to 5 log reduction, not an actual 5 log reduction. The text needs to be changed to reflect this. How were the aluminium coupons presented in the chamber and how does this relate to the inoculated masks (distance, orientation)? What was the maximum log reduction that could be achieved in this assay?

Some more interpretation of the surface types would be good for the discussion. You mention the 1860 was hydrophobic, but being made from polyester, was the 8210 hydrophobic as well? How did the inoculum present on the surfaces i.e. did they stay as droplets on the material or were they absorbed, and how do you think this would have affected the exposure? Do you think the colour differences of the masks played a role in the decontamination?

How close were your exposure doses to those that would compromise material integrity?

Supplementary file

You mention that “Details on virus propagation can be found in supplementary materials” but that is in the supplementary file. Please clarify.

What type of Biosafety cabinet was used for the drying of the masks?

Reviewer #2: The paper entitled “Practical considerations for Ultraviolet-C radiation mediated decontamination of N95 respirator against SARS-CoV-2 virus” is well written however would benefit from a more comprehensive review of the literature in the introduction and discussion . The contents add to the body of literature on decontamination of respirators and discuss important information on practical considerations for these processes. Of great importance is their discussion on variability in efficacy of UV-C depending on respirator model and mode of testing (swatches vs. whole masks). The article could be improved upon by including a more in depth look at current respirator UV-C disinfection practices and the advantages / disadvantages of these methods. I have a few minor comments and questions.

Questions and comments:

Page 2. In the introduction, address if any facilities are using UV-C decontamination for respirators currently or during the peak of the pandemic? This would put the article into context with current practices and would be helpful either in the introduction or discussion. Examples are Ozog et al. 2020 and Golladay et al. 2021.

Page 2: In the introduction or discussion include the benefits / disadvantages to respirator disinfection with UV-C vs. other methods. This will give the reader a more comprehensive view on what is practical for their facility.

Page 3. Instead of referring to the ambiguous industry standard it would be better to cite the FDA’s “recommendations for sponsors requesting EUA’s for decontamination and bioburden reduction systems for surgical masks and respirators during the (COVID-19) public health emergency” document. Include in the discussion or introduction that there is currently only 1 UV-C device with an EUA for respirator disinfection.

Page 4. Mask inoculation and UV-C exposure – indicate that only the exterior of the mask was tested. This limits use of the respirator to the to the same user. Do you have a comment on importance (or lack there of?) of disinfecting the internal fibers and interior of the respirator?

Page 4. The description of the UV-C disinfection device should be under materials and methods, not results and discussion heading. If possible, it would be helpful to include an image of the device and placement of the mask in the supplementary files.

S1 File: Extended Material and Methods page 2 – indicate source and model for calibrated UV-C sensors.

Page 5. Figure: UV-C decontamination of multiple locations on two models of N95 respirators: Panel B) Indicate in the legend that it is showing each site independently with the dots then an average of all sites with the bar graph.

Page 5. Reference FDA recommendations instead of “industry standard”.

Page 7 line 3 – Were irradiation doses carried out on the 8210 model as well? If the irradiation doses on the 8210 and 1860 are the same in the various locations, then the material of the mask is the major influencing factor. It is possible that there is a small change in the shape of the 8210 compared to the 1860 that hinders the efficacy of UV-C.

Page 7 line 14 and 15 – if you conducted this same testing on swatches of mask would you see this same result? This would solidify that it is the material that is the major factor in efficacy.

Did treated masks pass fit and filtration testing? If not tested, it needs to be indicated as a limitation of the study.

Testing of only the exterior of the mask needs to be included as a limitation of the study.

Discussion: It would make sense that the center of the mask would have the highest irradiation levels since it is closes and most parallel to the LEDs however it does not. The best reduction is occurring at the edges of the mask, any thoughts on why that is?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Oct 12;16(10):e0258336. doi: 10.1371/journal.pone.0258336.r002

Author response to Decision Letter 0


16 Jul 2021

We thank the reviewers for their feedback on the original manuscript and for the suggestions they made to improve our article. We have incorporated most of the suggestions made by the reviewers. A point-by-point response to the reviewers’ comments and questions can be found in the document named "Response to reviewers".

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Ginny Moore

27 Sep 2021

Practical considerations for Ultraviolet-C radiation mediated decontamination of N95 respirator against SARS-CoV-2 virus

PONE-D-21-00512R1

Dear Dr. Stanley,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Ginny Moore

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Please check the last line on page 2 of the revised document "4 of the 3 most promising methods"

Please check title of Table and confirm that "average" is the mean (or not)

Page 10 of the revised document - you mention "large variability". Whilst this is  illustrated to some extent in the figure, you could consider adding this data to the table (e.g. providing a standard deviation or range of reductions) 

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Ginny Moore

1 Oct 2021

PONE-D-21-00512R1

Practical considerations for Ultraviolet-C radiation mediated decontamination of N95 respirator against SARS-CoV-2 virus

Dear Dr. Stanley:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ginny Moore

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Extended material and methods.

    (DOCX)

    S2 File. Minimal data set.

    (XLSX)

    S1 Fig. Photo of a N95 respirator in the UVGI device.

    Front panel was removed for visibility.

    (TIF)

    S2 Fig. Custom N95 respirator with calibrated sensors used for the measurement and according irradiance measurement at each site.

    (TIFF)

    S3 Fig. Comparison of virus recovery from unirradiated mask sites after virus desiccation to control virus added directly into recovery media.

    (TIFF)

    S1 Table. Calculated doses delivered at each location for each exposure.

    Doses are calculated based on irradiance measurements made with the custom N95 respirator with calibrated sensors. Units are in mJ/cm2.

    (DOCX)

    S2 Table. Maximum log reduction achievable for each mask location.

    (DOCX)

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES